The initiative is the result of collaboration between the New York City Department of Health, the U.S. Department of Energy, the Nuclear Threat Initiative and the New York Police Department. The devices containing the chemical include machines used for cancer research and preparing blood donations, and will be replaced by alternative x-ray technologies.
“I am thrilled that private hospitals and universities in New York City have committed to removing these devices. While many of them have saved countless lives through cancer research and blood transfusion preparation, we must limit their risk of becoming objects for terror,” said Health Commissioner Mary Bassett, MD.
The hospitals participating in the program include Albert Einstein College of Medicine, Columbia University Medical Center, NYC Health + Hospitals-Bellevue, Maimonides Medical Center, Montefiore Medical Center, Mount Sinai Health System, Northwell Health Lenox Hill Hospital and Long Island Jewish Medical Center, NYU Langone Health, New York Blood Center, New York-Presbyterian Hospital, Rockefeller University and Weill Cornell Medicine.
More articles on hospital-physician relationships:
Why having a baby may prevent women from pursuing surgical residencies
5 Florida Hospital physicians describe status of Puerto Rico’s health system 2 weeks after hurricane
Mount Sinai staff experiences coma, ICU environment from patient’s point of view
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.